E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases

Isai Pratha Karthik1, Pavitra Desai1, Sudarkodi Sukumar1

  • 1From the Laboratory of Molecular Virology, National Cancer Tissue Biobank, Bhupat and Jyoti Mehta School of Biosciences, Department of Biotechnology, Indian Institute of Technology-Madras, Chennai 600 036, India and.

Insights

E4BP4 represses tumor suppressor RASSF8 expression via epigenetic mechanisms involving G9a and SUV39H1. This finding offers insights into breast cancer progression and potential therapeutic targets.

Area of Science:

  • Molecular Oncology
  • Epigenetics
  • Cancer Biology

Background:

  • RAS proteins are key oncogenes, with nonenzymatic RAS effectors (RASSF family) exhibiting tumor-suppressive roles.
  • While most RASSF members are epigenetically silenced by hypermethylation, RASSF8 downregulation mechanisms in cancer remain unclear.

Purpose of the Study:

  • To elucidate the mechanism of RASSF8 downregulation in cancer.
  • To identify transcriptional modulators and epigenetic factors affecting RASSF8 expression.

Main Methods:

  • Investigated the role of E4BP4 in regulating RASSF8 expression.
  • Assessed the involvement of histone methyltransferases G9a and SUV39H1.
  • Correlated RASSF8 and E4BP4 expression in breast tumor samples.

Main Results:

  • Identified E4BP4 as a transcriptional repressor of RASSF8.
  • Demonstrated that E4BP4 utilizes G9a and SUV39H1 to repress RASSF8 expression.
  • Observed a negative correlation between RASSF8 and E4BP4 in breast tumors.
  • Showed E4BP4 antagonizes RASSF8's anti-proliferative and pro-apoptotic effects.

Conclusions:

  • E4BP4 epigenetically represses RASSF8 expression through histone methyltransferases.
  • This mechanism contributes to RASSF8 downregulation in breast cancer.
  • Findings provide insights into RASSF8 regulation and suggest therapeutic strategies.

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.3K
Histone Modification02:32

Histone Modification

4.6K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.9K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K